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        Introduction 
  Steroid receptors, in addition to regulating the transcription of 
specifi  c genes (  Mangelsdorf et al., 1995  ), trigger rapid effects in 
the extra nuclear compartment (for review see   Migliaccio et al., 
2007 a). It is expected that hormone action depends on the integra-
tion of these different receptor activities (  Vicent et al., 2006  ). 
  Localization and action of estradiol receptor      (ER  )  are 
regulated by multiple factors, including interaction with signal-
ing effectors or other proteins, such as the metastatic tumor an-
tigen or the modulator of nongenomic action of steroid receptors 
(MNAR;   Kumar et al., 2002  ;   Vadlamudi et al., 2005  ;   Gururaj 
et al., 2006  ). Deregulation of these processes causes ER     mis-
localization and may trigger tumor progression. Overexpression 
of the EGF receptor is a hallmark of aggressive human breast 
cancers (  Slamon et al., 1989  ), and cross talk between ER     and 
growth factor signaling has emerged as a critical factor in endo-
crine resistance through the control of the subcellular localization 
of ER     signaling components (  Saporita et al., 2003  ;   Gururaj 
et al., 2006  ). ER association with MNAR may sequester ER in 
the cytoplasm/membrane (  Vadlamudi et al., 2005  ), thus enhanc-
ing the nongenomic effects of ER     and resulting in tumori-
genesis, as well as the anti-hormone resistance of breast cancer 
cells (  Vadlamudi et al., 2005  ;   Gururaj et al., 2006  ). Expression 
of a shortened form of the metastatic tumor antigens sequesters 
ER     in the cytoplasm and leads to malignant phenotypes by 
enhancing ER     cytoplasmic functions in hormone-dependent 
breast cancer cells (  Kumar et al., 2002  ). These data imply that 
cytoplasmic localization of ER     provides a mechanism to 
control signal transduction  –  dependent functions, such as DNA 
synthesis and anchorage-dependent growth of target cells. 
They suggest that the ER     localization has functional implica-
tions in breast cancer progression. 
  Steroid receptors undergo nucleocytoplasmic shuttling 
(for review see   DeFranco, 2001  ). In the presence of a ligand, 
glucocorticoid receptors (GR), androgen receptors (AR), thy-
roid hormone receptors (TR), and progesterone receptors (PgR) 
rapidly shuttle between the nuclei and cytoplasm (  DeFranco, 
  I
n breast cancer cells, cytoplasmic localization of the 
estradiol receptor      (ER    ) regulates estradiol-dependent 
S phase entry. We identiﬁ  ed a nuclear export sequence 
(NES) in ER     and show that its export is dependent 
on both estradiol-mediated phosphatidylinositol-3-kinase 
(PI3K)/AKT activation and chromosome region main-
tenance 1 (CRM1). A Tat peptide containing the ER     
NES disrupts ER      –  CRM1 interaction and prevents nuclear 
export of ER    - and estradiol-induced DNA synthesis. 
NES-ER     mutants do not exit the nucleus and inhibit 
estradiol-induced S phase entry; ER    -dependent tran-
scription is normal. ER     is associated with Forkhead proteins 
in the nucleus, and estradiol stimulates nuclear exit 
of both proteins. ER     knockdown or ER     NES mutations 
prevent ER     and Forkhead nuclear export. A mutant 
of forkhead in rhabdomyosarcoma (FKHR), which cannot 
be phosphorylated by estradiol-activated AKT, does not 
associate with ER     and is trapped in the nucleus, blocking 
S phase entry. In conclusion, estradiol-induced AKT-
dependent phosphorylation of FKHR drives its association 
with ER    , thereby triggering complex export from the 
nucleus necessary for initiation of DNA synthesis and 
S phase entry.
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nuclear receptor to the basal level by 1 h. 
[ID]FIG1[/ID]  Representative images 
of one of these experiments are presented in the supplemental 
materials, together with the parallel change in cytoplasmic re-
distribution of the receptor (Fig. S1 a and Fig. S1 b, left, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200712125/DC1). 
Immunoblot analysis of cell lysates does not reveal any signifi  -
cant change in ER     level (Fig. S1 c), which suggests that the 
observed decrease in ER     nuclear localization is caused by nu-
clear export of the receptor. 
  Quiescent MCF-7 cells were next transiently transfected 
with a full-length ER     cDNA subcloned into the GFP plasmid 
(pEGFP-HEG0; HEG0 represents the wtER    ). In   Fig. 1 b  , the 
quantitative count of cells with nuclear fl  uorescence shows that 
hormone treatment triggers nuclear accumulation of GFP-ER    
after 30 min in the absence of any signifi  cant change in GFP-
wtER     expression (  Figs. 1 b   and S1 c). By 1 h, the nuclear GFP-
wtER     decreases to the basal level, whereas no traffi  cking of 
GFP-wtER     was detectable in untreated cells (  Fig. 1 b  ). Repre-
sentative images of one of these experiments are presented in 
Fig. S1 b (right). In addition, GFP alone was insensitive to estra-
diol treatment when overexpressed in MCF-7 cells (unpublished 
data). This pattern of traffi  cking is similar to that observed for 
endogenous ER    . Furthermore, the partial antagonist, 4-OH-
  tamoxifen, prevents the observed nucleocytoplasmic shuttling 
of GFP-wtER     in response to hormonal treatment (  Fig. 1 b  ). 
  To exclude the potential contribution of de novo GFP-
ER     synthesis to its reemergence in the cytoplasm 1 h after es-
tradiol treatment, we included actinomycin D in the medium 
during hormone stimulation. No signifi  cant change in the estradiol-
induced redistribution of GFP-wtER     (  Fig. 1 c  ) or in protein 
expression was observed (Fig. S1 c). Therefore, the chimeric 
protein in cytoplasm is from nuclear export rather than from 
de novo synthesis. Because actinomycin D inhibits the nuclear 
import of the NES-containing REV protein (  Henderson, 2000  ), 
and the GFP-wtER     dynamic redistribution is not modifi  ed by 
actinomycin D (  Fig. 1 c  ), it is likely that cytoplasmic relocaliza-
tion of the chimera depends on nuclear export rather than inhi-
bition of nuclear import. 
  Because data in   Fig. 1 (a  –  c  ) show that ER     export shortly 
occurs upon estradiol treatment of MCF-7 cells, we hypothesized 
a role for a rapid action of estradiol in the ER     intracellular 
traffi  c. Activation of the PI3K  –  AKT pathway, for instance, modu-
lates the traffi  cking of various proteins, including FKHR, nuclear 
factor     B, glycogen synthase kinase-3     , Mdm2, p27 (for review 
see   Kau and Silver, 2003  ), and PTEN (phosphatase and tensin 
homologue deleted on chromosome;   Liu et al., 2007  ). Because 
of the rapid activation of this pathway by estradiol treatment 
of breast cancer cells (Fig. S1 d;   Castoria et al., 2001,     2004  ), we 
verifi  ed its contribution to the ER     nuclear export. Quiescent 
MCF-7 cells were then transiently transfected with the dominant-
negative form of the regulatory subunit of PI3K, p85     (  p85  ; 
  Dhand et al., 1994  ), or the catalytically inactive version of AKT 
(K179M; dominant-negative AKT). In   Fig. 1 d  , the count of trans-
fected cells showing ER     nuclear fluorescence indicates that 
overexpression of either    p85    or dominant-negative AKT in-
duces nuclear retention of ER     in 60-min estradiol-treated MCF-7 
cells. Transfection of cells with the Myc-tagged pSG5 control 
2001  ). Hormone withdrawal from cells induces accumulation 
of GR and AR in the cytoplasm (  Tyagi et al., 2000  ). ER     also 
shuttles from the nuclei to the cytoplasm, and the antiestrogen, 
ICI 182, 780, disrupts this process (  Dauvois et al., 1993  ). Ligand 
binding and protein  –  protein interactions can signifi  cantly infl  u-
ence the nucleocytoplasmic shuttling of the chimeric GFP-ER    
(  Maruvada et al., 2003  ). However, although the mechanism of 
nuclear import of steroid receptors is well documented, the 
mechanism of export is still unclear (  DeFranco, 2001  ). 
  The best-characterized nuclear export pathway uses chro-
mosome region maintenance 1 (CRM1) as a receptor for pro-
teins with leucine-rich nuclear export signals (NESs;   Fornerod 
et al., 1997 ;  Fukuda et al., 1997 ). Leptomycin B (LMB), through 
covalent binding to CRM1, inhibits CRM1-dependent nuclear 
export (  Kudo et al., 1998  ). Confl  icting data have been reported 
on inhibition of steroid receptor export by LMB treatment. 
Although it is generally accepted that steroid receptors lack 
classical leucine-rich NESs, they do have sequences with lim-
ited homology to NESs (  Liu and De Franco, 2000  ). Because the 
exact spacing of the leucine/hydrophobic residues in the NES of 
each protein is subject to variation, it can be diffi  cult to defi  ne 
a NES on this basis alone (  Nigg, 1997  ). Under some circum-
stances, LMB treatment does indeed inhibit the nuclear export 
of steroid receptors (  Savory et al., 1999  ;   Prufer and Barsony, 
2002  ;   Maruvada et al., 2003  ;   Saporita et al., 2003  ). 
  Here, we fi  nd that in MCF-7 cells, ER     is a nucleo-
cytoplasmic shuttling protein whose traffi  c out of nuclei is regu-
lated by estradiol activation of the phosphatidylinositol-3-kinase 
(PI3K)  –  AKT pathway and depends on CRM1. By combining 
different approaches, we identifi  ed a hormone-dependent and 
CRM1-directed NES in the ER     hormone-binding domain. 
The potential interest of these fi  ndings is highlighted by the ob-
servation that the ER     NES shows signifi  cant homology with 
sequences of other steroid receptors. A peptide mimicking the 
NES-ER     specifi  cally sequesters the receptor in the nuclei and 
interferes in hormone-triggered S phase entry in these cells. 
Site-directed mutagenesis of the ER     NES inhibits forkhead in 
rhabdomyosarcoma (FKHR) nuclear export, the estradiol-induced 
cytoplasmic relocalization of receptor, and DNA synthesis. Target-
ing ER     by siRNA retains FKHR in the nuclear compartment 
of estradiol-treated MCF-7 cells. 
  This study provides a new link between the rapid extra-
nuclear action of estradiol and ER     nuclear export, as well as a 
proliferative role of receptor nuclear export, which is closely 
associated to FKHR export. 
  Results 
  Estradiol regulates ER     shuttling in 
MCF-7 cells 
  Localization of endogenous ER     in quiescent MCF-7 cells was 
verifi  ed by immunofl  uorescence using two different antibodies di-
rected against either a C-terminal (H222 mAb;   Katzenellenbogen 
et al., 1987 ) or N-terminal epitope of ER   (A314 mAb;  Abbondanza 
et al., 1998  ).   Fig. 1 a   shows that, regardless of the antibody 
used, estradiol treatment of MCF-7 cells induces nuclear trans-
location of ER     after 30 min, followed by a decrease of the 329 ER     NUCLEAR EXPORT AND S PHASE ENTRY IN ESTRADIOL-STIMULATED CELLS   • Lombardi et al. 
containing proteins by preventing their association with the CRM1 
export receptor (  Kudo et al., 1998  ). A quantitative analysis of 
transfected cells shows that LMB treatment results in mainte-
nance of nuclear GFP-wtER     1 h after estradiol stimulation 
(  Fig. 1, e and f  ). LMB treatment alone does not have an effect 
plasmid does not interfere in the traffi  cking of ER   .  Images  of 
one experiment in   Fig. 1 d   are presented in Fig. S1 e. 
  To determine if CRM1 plays a role in ER     nuclear  exit, 
MCF-7 cells were treated with LMB in addition to estradiol. 
This antifungal compound blocks the nuclear export of NES-
  Figure 1.       Estradiol induces nuclear export of ER    , which is regulated by the PI3K  –  AKT pathway and depends on CRM1.   Quiescent MCF-7 cells were used. 
(a) Cells were untreated or treated with 10 nM estradiol (E  2  ) for the indicated times (min). ER     localization was analyzed by immunoﬂ  uorescence using 
the indicated antibodies. (b and c) Cells were transfected with GFP-wtER     then left untreated or treated with the indicated compounds. OH-tamoxifen (Tx; 
AstraZeneca) was used at 0.1   μ  M; actinomycin D (Act D) was added at 5   μ  g/ml, 1 h before estradiol stimulation. GFP-wtER     localization was determined 
by ﬂ  uorescence. (d) Cells were transfected with the indicated plasmids and left untreated or treated with 10 nM estradiol for the indicated times (min). 
The Myc-tagged pSG5,     p85    , or Myc-His  –  tagged dominant-negative AKT ectopically expressed in MCF-7 cells were visualized by immunoﬂ  uorescence, 
as described in Materials and methods. ER     localization was analyzed by immunoﬂ  uorescence using the rat H222 anti-ER     mAb. (e) Cells were transfected 
with GFP-wtER     and then left untreated or treated with 10 nM estradiol in the absence or presence of LMB (at 5 ng/ml). LMB was added 30 min before the 
hormone. Cells were also treated with LMB in the absence of hormone. GFP-wtER     localization was determined by ﬂ  uorescence. (a, b, c, d, and e) Cells 
that fell into the category of exclusively nuclear ﬂ  uorescence were scored, and data was expressed as a percentage of total cells (in a) or transfected cells 
(in b, c, d, and e). Data were derived from at least 1,000 scored cells. The results of several independent experiments were averaged; means and SEM are 
shown.   n   represents the number of experiments. (f) Images from one experiment in panel e were captured. Panels show GFP-wtER     localization in MCF-7 
cells stimulated for 60 min with estradiol (E  2  ) in the absence or presence of LMB. Bar, 5   μ  m. (g)  
35  S-labeled HA-CRM1 was incubated with recombinant 
ER     in the absence or presence of 10 nM estradiol. The puriﬁ  ed recombinant RanQ69L (at 1   μ  M) was included in the incubation mixture of each sample. 
Proteins were immunoprecipitated with rabbit polyclonal anti-ER     antibody. Eluted proteins were immunoblotted with anti-ER     antibody (top) or revealed 
by ﬂ  uorography (bottom).     JCB • VOLUME 182 • NUMBER 2 • 2008  330
  Figure 2.       The ER     444  –  456 sequence restores export activity of the NES-deﬁ  cient REV1.4-GFP.   Growing MCF-7 cells were used. (a and b) Cells were 
transfected with the indicated constructs. After transfection, the cells were left untreated (no drug) or treated with actinomycin D (ActD) at 5   μ  g/ml, alone 
or together with 5 ng/ml LMB. The subcellular distribution of GFP proteins was determined by ﬂ  uorescence microscopy, and cells that fell into the category 
of exclusively nuclear ﬂ  uorescence were scored. Data are expressed as a percentage of transfected cells, with mean values taken from at least three ex-
periments. For each experiment, at least 600 cells were scored. (b) Images of one experiment in panel a. (c) The wt ER     444  –  456 sequence (NES ER     
wt) as well as its mutated version (NES ER     mutant). The putative NES-ER     sequence is indicated by the underlined amino acids, which were substituted 
with alanine residues in the mutant sequence. The NES-ER     wt as well as the NES-ER     mutant subcloned into the Rev mutant were transfected (d and e) in 
growing MCF-7 cells. After transfection, the cells were left untreated (    ) or treated with 5   μ  g/ml Act D (+). The percentage of cells with nuclear GFP protein 
was determined by ﬂ  uorescence microscopy and graphically shown in panel d. Data were derived from at least 600 scored cells. The results of several 
independent experiments were averaged. (a and d) Means and SEM are shown.   n   represents the number of experiments. (e) Images of one experiment 
in panel d. Bars, 5   μ  m     331 ER     NUCLEAR EXPORT AND S PHASE ENTRY IN ESTRADIOL-STIMULATED CELLS   • Lombardi et al. 
on the localization of GFP-wtER     (  Fig. 1, e and f  ). Thus, the 
effect of LMB treatment on ER     localization suggests that this 
receptor, when bound to the hormone, is exported from nuclei 
through the CRM1 – exportin pathway. Estradiol induces a strong 
interaction between recombinant ER     and in vitro translated 
CRM1 (  Fig. 1 g  ) when active Ran (Ran-GTP;   Askjaer et al., 1999  ) 
was included as a GTPase-defi  cient RanQ69L mutant (  Bischoff 
et al., 1994  ). 
  This set of experiments shows that estradiol activation of 
the PI3K  –  AKT pathway modulates nuclear export of ER     and 
that CRM1 contributes to estradiol-mediated ER     nuclear  ex-
port in MCF-7 cells. 
  Identiﬁ  cation of an ER     nuclear 
export sequence 
 Two  ER    mutants, HEG15 and HEG14, were subcloned into 
pEGFP. HEG15 (   282 – 595  HEG0)  contains  highly  conserved 
NLSs (2 and 3;   Guiochon-Mantel et al., 1991  ). It binds DNA 
but is unable to bind estradiol (  Ylikomi et al., 1992  ). In turn, 
HEG14 (    1  –  281) contains NLS1. It binds the hormone but does 
not bind DNA (  Ylikomi et al., 1992  ). The resulting chimeras, 
GFP-HEG15 and GFP-HEG14, were transiently transfected into 
quiescent MCF-7 cells. Consistent with previous fi  ndings (  Ylikomi 
et al., 1992  ), results in Fig. S2 (available at http://www.jcb.org/
cgi/content/full/jcb.200712125/DC1) show that neither GFP-
HEG15 nor GFP-HEG14 shuttle between the nucleus and the 
cytoplasm. Irrespective of the hormonal treatment, the fi  rst mu-
tant mostly resides in the nuclear compartment. Although GFP-
HEG14 contains the NLS1 sequence and binds the hormone, it 
does not enter nuclei even after estradiol addition. From these 
data, we speculated that the hormone-binding domain localized 
in the HEG14 mutant as well as NLSs (2 and 3) of ER     are both 
required for the estradiol-induced nuclear import of the recep-
tor. We next subcloned HE241G into pEGFP. This mutant con-
tains the hormone-binding domain and lacks the three NLSs. 
It is, in fact, prevalently localized in the cytoplasm regardless of 
estradiol treatment. The behavior of this mutant confi  rms that in 
the absence of NLS, the hormone-binding domain is not suffi  -
cient to induce nuclear translocation of the receptor. Because 
HEG15 is localized in the nuclear compartment and its localiza-
tion is unaffected by hormonal treatment of cells, we reasoned 
that the addition of NLSs to HEG14 might restore the estradiol-
induced import of ER    . Analysis of transfected cells with the 
resulting chimera, GFP-NLS/HEG14, showed not only nuclear 
import but also export similar to GFP-wtER     in response to 
estradiol treatment. These fi  ndings collected in Fig. S2 point to 
the presence of nuclear export sequences in the NLS  –  HEG14 
construct, which is made up of the NLSs and the hormone-binding 
domain of ER   . 
  It has been found that NLSs of the PgR are responsible for 
its nuclear export (  Guiochon-Mantel et al., 1994  ). Therefore, 
we studied whether NLSs are involved in ER     export  using 
in vivo export assay (  Henderson and Eleftheriou, 2000  ). In this 
assay, nuclear export sequences are identifi  ed by their ability to 
restore export activity of the NES-defi  cient REV1.4-GFP (Rev 
mutant) to levels similar to those observed with the wild-type 
(wt) pREV-GFP or the REV1.4-GFP NES (Rev positive control), 
in which the NES is the canonical export sequence of the REV 
protein. The NLS sequences of ER     were subcloned into the 
Rev mutant and expressed in MCF-7 cells. After transfection, 
cells were incubated in the absence or presence of actinomycin 
D because it causes cytoplasmic accumulation of the puta-
tive NES-containing REV protein by preventing nuclear im-
port of REV (  Henderson, 2000  ). Irrespective of experimental 
conditions, the Rev mutant NLS localizes in nuclei of MCF-7 
cells (  Fig. 2, a and b  ). 
[ID]FIG2[/ID]  In the same experiment, the Rev-positive 
control completely shifted to the cytoplasm in the presence of 
actinomycin D, whereas the Rev mutant NLS sequences from 
the ER     showed nuclear, sometimes nucleolar, staining. These 
data indicate that the NLS sequences of ER     are inactive in this 
export assay. 
  We then subcloned different sequences of ER     contain-
ing leucine residues into a Rev mutant. These constructs were 
transfected into MCF-7 cells and then analyzed for their abil-
ity to restore the nuclear export of the Rev mutant. Using this 
assay, we verifi  ed that ER     residues 427  –  456 induced a nu-
cleocytoplasm redistribution of Rev mutant in cells treated 
with actinomycin D (  Fig. 2, a and b  ). LMB treatment blocked the 
export activity of the 427  –  456 ER     sequence (  Fig. 2, a and b  ). 
Regardless of the experimental conditions, the leucine-rich 
296 – 335  ER    sequence was unable to drive the Rev mutant to 
the cytoplasm (  Fig. 2, a and b  ). These data show that the 427  –
  456 region is involved in the export of ER     through  CRM1/
exportin binding. 
  A thorough sequence analysis showed homology between 
the 444  –  456 amino acids of ER     and the conserved leucine-
rich and REV-like NES of p53 (residues 340  –  351;   Stommel et al., 
1999  ). A comparison of the homologous amino acids across 
the family of steroid receptors revealed a high level of sequence 
homology with ER  , PgR, AR, and GR. The alignment between 
the sequences is shown in Fig. S3 (a and b, available at http://
www.jcb.org/cgi/content/full/jcb.200712125/DC1). 
  The possibility that residues 444  –  456 of the ER     sequence 
contain the NES-ER     was further investigated. The 444  –  456 
ER     sequence were subcloned into the Rev mutant, as they 
were with a mutated version in which residues 444  –  456 were 
mutated from IILL to alanines (  Fig. 2 c  ). The ER     wt sequence 
(NES-ER     wt) was able to shift the Rev mutant into the cyto-
plasm of MCF-7 cells, whereas the mutated form of ER     (NES-
ER     mutant) failed to do so (  Fig. 2, d and e  ). This difference is 
even more evident in the presence of actinomycin D. 
  These results show that a small sequence of the ER    
hormone-binding domain contains a CRM1-mediated ER     NES. 
  A peptide mimicking the 444  –  456 ER     
sequence sequesters the receptor in 
the nuclear compartment and inhibits 
estradiol-induced S phase entry in breast 
cancer cells 
  Small cationic peptides (also called protein transduction do-
mains) derived from nucleic acid  –  binding proteins, such as 
HIV-Tat protein, deliver a myriad of peptides into animal models 
and   represent a biological and potentially therapeutic tool for 
targeting proteins into the cells (  Joliot and Prochiantz, 2004  ). JCB • VOLUME 182 • NUMBER 2 • 2008  332
ity assayed.   Fig. 4 d   shows that the constructs GFP-wtER    
and GFP-ER     IL are equally effi  cient in activating gene tran-
scription upon estradiol stimulation of the cells, with a sixfold 
induction of ERE-Luc activity. Transcriptional activation was 
almost undetectable in unstimulated cells or in cells expressing 
GFP alone. 
  In another set of experiments, we assessed the ability of 
GFP-wtER     and GFP-ER     IL to mediate estradiol-induced 
AKT activation as well as DNA synthesis when ectopically ex-
pressed in ER    -negative NIH3T3 fi  broblasts. We fi  rst verifi  ed 
that GFP-wtER     and its export mutant GFP-ER     IL both acti-
vate AKT upon estradiol stimulation of NIH3T3 cells (  Fig. 4 e  ). 
Although able to activate the nongenomic pathway usually en-
gaged by estradiol to transmit its mitogenic signal, the mutant 
GFP-ER    IL failed to induce S phase entry in fi  broblasts treated 
with estradiol (  Fig. 4 f  ). The mutant did not affect S phase entry 
induced by the receptor-independent serum stimulation (  Fig. 4 f  ). 
In contrast, the GFP-wtER     induced a robust BrdU incorpor-
ation in hormone-treated cells (  Fig. 4 f  ). As observed in MCF-7 
cells (  Fig. 3 e  ), addition of Tat-conjugated peptide inhibited 
the estradiol-induced S phase entry in fi  broblasts transfected 
with GFP-wtER    . Here again, the peptide did not interfere in 
DNA synthesis induced by serum stimulation of the same cells 
(  Fig. 4 f  , asterisks). 
  These experiments demonstrate that the leucine-rich se-
quence 444  –  456 of ER     contains a functional NES. Mutations 
in the core (IILL) of this sequence impair the estradiol-induced 
nuclear export of ER     and DNA synthesis without affecting 
the signal transduction pathway or gene transcription regulation 
by estradiol. 
  Estradiol regulates FKHR/ER     export 
  Estradiol activation of PI3K is required to drive MCF-7 cells 
into S phase ( Castoria et al., 2001 ). Activation of the PI3K – AKT 
pathway by estradiol regulates ER     nuclear export (  Fig. 1  ), and 
FKHR nuclear export depends on its phosphorylation by AKT 
(  Biggs et al., 1999  ). In addition, previous studies reported that 
an estradiol-dependent interaction between ER     and FKHR oc-
curs in vitro (  Schuur et al., 2001  ). Thus, we hypothesized a role 
for FKHR in both estradiol-regulated ER     nuclear export and 
cell cycle arrest mediated by the NES-ER     mutant. To analyze 
the role of FKHR in estradiol-induced DNA synthesis and ER    
nuclear export, quiescent MCF-7 cells were transiently trans-
fected with wt FKHR (GFP-FKHR wt) or a mutant containing 
a triple alanine substitution (GFP-FKHR AAA) that localizes in 
nuclei and blocks FKHR phosphorylation by AKT, thereby in-
ducing G1 arrest of cells (  Nakamura et al., 2000  ).   Fig. 5 a   shows 
that expression of this mutant reduced estradiol-triggered BrdU 
incorporation in MCF-7 cells, whereas expression of GFP-
FKHR wt did not. 
[ID]FIG5[/ID]  We then used confocal microscopy to analyze 
the role of FKHR in the estradiol-regulated subcellular distri-
bution of ER    . Although ectopically expressed GFP-FKHR wt 
or GFP alone did not modify the 60-min estradiol-induced nu-
clear export of ER    , the mutant GFP-FKHR AAA sequestered 
ER     in the nuclear compartment at that time (  Fig. 5, b and d  ). 
Conversely, overexpression of the tagged NES-ER     mutant, 
Myc-ER     IL, resulted in retention of GFP-FKHR wt in the nuclear 
To trap ER     in the nuclear compartment of cells, we synthe-
sized a Tat-conjugated peptide construct corresponding to the 
residues 444  –  456 of ER     ( Fig.  3  a ). 
[ID]FIG3[/ID]  Confocal microscopy 
analysis revealed in preliminary experiments that the carboxy-
fl  uorescein-conjugated peptide translocated across the plasma 
membrane and, within 30 min, accumulated in nuclei of MCF-7 
cells (unpublished data). This peptide displaced the estradiol-
induced interaction between recombinant CRM1 and ER    
(  Fig. 3 b  ) and blocked the 60-min estradiol-induced nuclear ex-
port of GFP-wtER    , thus sequestering the receptor in nuclei 
(  Fig. 3, c and d  ). The Tat alone did not affect both the ER    –
  CRM1 interaction (  Fig. 3 b  ) as well as the traffi  cking of GFP-
wtER     (unpublished data). Furthermore, the Tat-conjugated 
peptide did not affect p27 nuclear export or p53 subcellular lo-
calization (Fig. S3, c and d), which indicates that it specifi  cally 
interferes in ER     localization. 
  The extranuclear activity of ER     triggers hormone-
dependent DNA synthesis (  Castoria et al., 1999  ), and ER    
sequestration in the cytoplasm increases its nongenomic ac-
tions and drives neoplastic transformation (  Kumar et al., 2002  ). 
  Fig. 3 e   shows that the Tat-conjugated peptide reduced estradiol-
induced DNA synthesis in MCF-7 cells by 60%. A negligible 
effect was observed in cells treated with Tat alone. Further-
more, the Tat peptide did not interfere in serum-induced DNA 
synthesis in MCF-7 cells (  Fig. 3 e  ), which indicates that the 
peptide specifi  cally interferes in estradiol action. Addition of 
the Tat-conjugated peptide at different times after estradiol 
stimulation shows that after 60 min, when ER     is almost com-
pletely exported from nuclei, the peptide does not affect S phase 
entry in MCF-7 cells (  Fig. 3 f  ), thus reinforcing the view that 
the estradiol-induced nuclear export of ER     plays a role in 
DNA synthesis. 
  ER     NES mutants do not exit nuclei and 
fail to mediate estradiol-induced DNA 
synthesis 
  Based on our fi  ndings (  Fig. 2  ), two mutants of GFP-wtER    
were prepared by site-directed mutagenesis to identify the NES-
ER     sequence and analyze the biological effects induced by these 
mutations.   Fig. 4 a   shows a schematic representation of the 
GFP-wtER     NES and its mutated versions, which were tran-
siently transfected into MCF-7 cells. 
[ID]FIG4[/ID]  Estradiol treatment induced 
nuclear export of GFP-wtER    , which contains the wild-type 
human ER    . In contrast, both mutants, GFP-ER     4A and GFP-
ER     IL, were unable to be exported from nuclei upon hormonal 
stimulation (  Fig. 4 b  ). Images in   Fig. 4 c   show the diffuse, some-
times extranuclear localization of GFP-wtER     in MCF-7 cells 
stimulated for 60 min with estradiol. Under these conditions, a 
nuclear/nucleolar localization of both GFP-ER     4A and GFP-
ER     IL was detected. 
  We then verifi  ed the ability of the GFP-ER     IL mutant to 
activate estradiol-induced gene transcription. To this end, we 
used ER    -negative NIH3T3 fi  broblasts (  Castoria et al., 1999  , 
  2003  ). The Western blot in   Fig. 4 d   (inset) confi  rms that NIH3T3 
fi  broblasts are indeed ER     negative. The cells were then tran-
siently transfected with GFP-wtER   ,  GFP-ER    IL, or GFP alone. 
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ER    -positive breast cancer cells, FKHR moves from nucleus to 
the cytoplasm by a mechanism depending on ER   . 
  Finally, we observed by Western blot analysis that es-
tradiol stimulation of quiescent MCF-7 cells rapidly induces 
FKHR phosphorylation in Ser256 (  Fig. 6 a  ). 
[ID]FIG6[/ID]  To complement 
colocalization experiments, we next analyzed the interaction 
compartment 60 min after estradiol treatment of MCF-7 cells 
(  Fig. 5, c and d  ). Thus, estradiol simultaneously regulates ER   - 
and FKHR-associated nuclear export. 
  We then verifi  ed that silencing of ER     by siRNA retains 
GFP-FKHR wt in the nuclear compartment of 60-min hormonal-
treated MCF-7 cells (  Fig. 5 e  ). These fi  ndings confi  rm that, in 
  Figure 3.       A peptide mimicking the ER     444  –  456 sequence displaces the CRM1  –  ER     interaction, sequesters the receptor into nuclei, and inhibits 
S phase entry in estradiol-treated MCF-7 cells.   (a) The amino acidic sequence of the Tat-conjugated ER     (444  –  456) peptide. (b)  
35  S-labeled HA-CRM1 
was incubated with recombinant ER     from baculovirus in the absence or presence of 10 nM estradiol alone or together with a 200-fold excess of the 
Tat-conjugated peptide (Tat-pep). A 200-fold excess of a nonspeciﬁ  c peptide (Tat) was used as a control. CRM1 was immunoprecipitated with the anti-HA 
mAb, and proteins in immunocomplexes were revealed by ﬂ  uorography (top) and immunoblotting with the anti-ER     antibody (bottom). (c) Quiescent 
MCF-7 cells transfected with GFP-HEG0 were incubated for 1 h with the Tat-conjugated peptide (Tat pep). Thereafter, the cells were left untreated or 
treated for the indicated times with 10 nM estradiol. The proportion of cells with nuclear GFP-wtER     protein was determined by ﬂ  uorescence microscopy 
and graphically shown. For each experiment, at least 200 cells were scored. The results of several independent experiments were averaged.   n   repre-
sents the number of experiments. (d) Images of one experiment in panel c. This shows the localization of GFP-wtER     in MCF-7 cells treated for 60 min 
with estradiol in the absence or presence of Tat-pep. Bar, 5   μ  m. (e) MCF-7 cells on coverslips were made quiescent or serum starved (maintained for 24 h 
in 0.5% FCS). The cells were incubated for 24 h with 10 nM estradiol or 20% serum in the absence or presence of the Tat-conjugated ER     (444  –  456) 
peptide (Tat-pep) or Tat alone. After in vivo pulse with BrdU, DNA synthesis was analyzed and BrdU incorporation was expressed as a percentage 
of total nuclei. For each experiment, at least 200 cells were scored. The results of several independent experiments were averaged.   n   represents the 
number of experiments. (f) Quiescent MCF-7 cells were stimulated with 10 nM estradiol for 24 h, and the Tat peptide was added after the addition of 
the hormone at the time points indicated in the ﬁ  gure. After an in vivo pulse with BrdU, DNA synthesis was analyzed and expressed as a percentage 
of BrdU incorporation inhibition. For each experiment, at least 300 cells were scored. The results of two independent experiments were averaged. 
(c, e, and f) Means and SEM are shown.     JCB • VOLUME 182 • NUMBER 2 • 2008  334
  Discussion 
  Nucleocytoplasmic shuttling of proteins plays a critical role 
in cell function (for review see   Kau and Silver, 2003  ). Most of 
the ER   is localized in nuclei of hormone target cells ( Stenoien 
et al., 2001  ), and its best-known function as a ligand-activated 
transcription factor requires nuclear localization (  Mangelsdorf 
et al., 1995 ). Much evidence, however, has demonstrated rapid, 
extranuclear action of ER     (for review see   Migliaccio et al., 
2007a  ). Ligand stimulation of different cell types recruits different 
between ER     and FKHR in coimmunoprecipitation experi-
ments. Data in   Fig. 6 b   show that 30-min hormonal stimula-
tion increases the association of FKHR wt with ER     in  MCF-7 
cells (  Fig. 6 b  , left). Whatever the experimental condition, the 
mutant FKHR AAA does not coimmunoprecipitate with ER    
(  Fig. 6 b  , right), therefore implicating that phosphorylation of 
FKHR induced by estradiol is required for its association with 
the receptor. 
 These  fi  ndings led us to hypothesize the model of ER    
export and its interplay with FKHR depicted in   Fig. 6 c  . 
  Figure 4.       Mutations of NES-ER     impair nuclear export of full-length ER     and prevent S phase entry in MCF-7 cells stimulated by estradiol.   (a) The wild-
type NES-ER     endowed in the amino acid 444  –  456 sequence is shown in bold. Mutated amino acids are underlined. The NES mutants, GFP-HEG4A and 
GFP-HEGIL, were prepared as described in Materials and methods. (b) Quiescent MCF-7 cells were transfected with the indicated plasmids and then left 
unstimulated or stimulated with 10 nM estradiol for the indicated times. The percentage of cells with nuclear GFP protein was determined by ﬂ  uorescence 
microscopy and shown graphically. For each experiment, at least 150 cells were scored. The results of different independent experiments were averaged; 
  n   represents the number of experiments. (c) Images of one experiment in panel b that shows the intracellular distribution of GFP-wtER    , GFP-ER     4A, or 
GFP-ER     IL in MCF-7 cells treated for 1 h with estradiol. Bar, 5   μ  m. (d  –  f) Growing NIH3T3 ﬁ  broblasts were used. The Western blot in panel d shows that 
NIH3T3 ﬁ  broblasts are ER     negative. In the graph in panel d, cells were transfected with an ERE-Luc construct along with the indicated plasmids. After 
transfection, the cells were made quiescent and then left unstimulated or stimulated with 10 nM estradiol. Luciferase activity was assayed, normalized using 
    -gal as an internal control, and expressed as fold induction. (e) Cells were transfected with the indicated plasmids and made quiescent. The cells were left 
unstimulated or stimulated for 5 min with 10 nM estradiol. Lysates were analyzed for AKT activation using the anti  –  P-Ser-473 antibody (bottom). The nitro-
cellulose ﬁ  lters were then reprobed with anti-AKT antibody (top). (f) Cells on coverslips were transfected with the indicated plasmids and made quiescent. 
The cells were left unstimulated or stimulated for 18 h with 10 nM estradiol or 20% serum. In cells transfected with GFP-wtER    , the inhibitory action of Tat 
peptide on estradiol-induced BrdU incorporation was analyzed by including this compound (at 1   μ  M) to the cell medium (bars with asterisks). After in vivo 
pulse with BrdU, DNA synthesis was analyzed by immunoﬂ  uorescence. In transfected cells, BrdU incorporation was calculated by the formula (percentage 
of BrdU-positive cells = [number of transfected-positive cells/number of transfected cells]   ×   100) and compared with BrdU incorporation of untransfected 
cells from the same coverslips. For each plasmid, data were derived from at least 500 scored cells. The results of several independent experiments were 
averaged;   n   represents the number of experiments. (b, d, and f) Means and SEM are shown.     335 ER     NUCLEAR EXPORT AND S PHASE ENTRY IN ESTRADIOL-STIMULATED CELLS   • Lombardi et al. 
supported by the observation that a classical mouse AR, which 
is expressed at a very low level in NIH3T3 fi  broblasts, does 
not enter nuclei and does not activate gene transcription in 
androgen-stimulated cells. Nevertheless, it recruits several sig-
naling effectors that control hormone-induced S phase entry 
and cytoskeleton changes in fi  broblasts (  Castoria et al., 2003  ). 
Rat uterine stromal cells, although they express low levels of 
transcriptionally incompetent PgR, respond to progestin with 
signaling effectors to ER     or ER    , which in turn leads to sig-
nal transduction pathway activation (  Migliaccio et al., 2000  ; 
  Castoria et al., 2001  ). A transcriptionally inactive ER     mu-
tant, permanently residing in the cytoplasm, mediates S phase 
entry triggered by estradiol activation of the Src  –  Ras  –  ERK and 
PI3K – AKT  pathways  ( Castoria  et  al.,  1999 ,   2004 ). These  fi  nd-
ings suggest a proliferative function for this extranuclear receptor 
that is independent of its transcriptional activity. This view is 
  Figure 5.       FKHR nuclear export: regulation by estradiol and a role in hormone-induced DNA synthesis in MCF-7 cells.   Quiescent MCF-7 cells on coverslips 
were used. (a) Cells were transfected with the indicated plasmids then left unstimulated or stimulated for 24 h with 10 nM estradiol. After in vivo pulse with 
BrdU, DNA synthesis was analyzed by immunoﬂ  uorescence and BrdU incorporation was calculated as in   Fig. 4  . (b) Cells were transfected with the indicated 
plasmids then left unstimulated or stimulated with 10 nM estradiol for the indicated times. Endogenous ER     localization as well as expression of GFP, GFP-
FKHR wt, or GFP-FKHR AAA mutant was monitored by confocal microscopy. Cells that fell into the category of exclusively ER     nuclear ﬂ  uorescence were 
scored, and data were expressed as a percentage of transfected cells. (c) Cells were cotransfected with the indicated plasmids then left unstimulated or 
stimulated with 10 nM estradiol for 60 min. Localization of GFP-FKHR wt, Myc-HEG0, or Myc-HEGIL mutant was monitored by confocal microscopy. Cells 
that fell into the category of exclusively FKHR nuclear ﬂ  uorescence were scored and the data were expressed as a percentage of cotransfected cells. For each 
experiment in panels a  –  c, data were derived from at least 500 scored cells. The results of several independent experiments were averaged;   n   represents the 
number of experiments. (d) Images from one experiment in b or c are shown. They represent the staining of endogenous ER     (red) in MCF-7 cells expressing 
GFP-FKHR wt (left, green) or the mutant, GFP-FKHR AAA (middle, green), and treated for 60 min with estradiol. (right) The staining of Myc-tagged NES-ER     
mutant (red) in MCF-7 cells coexpressing GFP-FKHR wt (green) and treated for 60 min with estradiol. Merged images are also shown on the bottom. Bar, 5   μ  m. 
(e) The cells were cotransfected with ER     siRNA (ER     siRNA) or nontargeting siRNA (nt siRNA) and GFP-FKHR wt. The cells were then left unstimulated or 
stimulated with 10 nM estradiol for the indicated times. GFP-FKHR wt localization was monitored by confocal microscopy. Cells that fell into the category of 
exclusively GFP-FKHR wt nuclear ﬂ  uorescence were scored and data were expressed as a percentage of transfected cells. Data were derived from at least 
200 scored cells. The results of two independent experiments were averaged. The blot in panel e conﬁ  rms the silencing of ER     in MCF-7 cells transfected with 
ER     siRNA (top). The bottom shows the blot of loading proteins revealed using the anti-tubulin antibody. (a, b, c, and e) Means and SEM are shown.     JCB • VOLUME 182 • NUMBER 2 • 2008  336
444 – 456  sequence  of  ER    contains a functional NES, which 
is sensitive to LMB treatment. A Tat-conjugated peptide mim-
icking this amino acid sequence displaces the in vitro inter-
action between ER     and CRM1. These fi  ndings support the 
conclusion that the 444  –  456 sequence contains a putative NES. 
Mutations in the core of this sequence impair estradiol-induced 
nuclear export of full-length ER     in MCF-7 cells. The 444  –  456 
sequence shows homology with the conserved leucine-rich and 
REV-like NES of p53 (340  –  351; Fig. S3 a;   Stommel et al., 1999  ). 
Remarkably, the 444  –  456 region of ER     is conserved in other 
steroid receptors, such as ER    , PgR, AR, GR, and MR (Fig. S3 b), 
which suggests that such a sequence is responsible for the CRM1-
dependent nuclear export of most steroid receptors. This view is 
in agreement with the inhibition of nuclear export of different 
steroid receptors by LMB treatment described by several groups 
under different experimental conditions (  Savory et al., 1999  ; 
  Prufer and Barsony, 2002  ;   Maruvada et al., 2003  ). 
 ER    localization was also modulated by a Tat-conjugated 
peptide mimicking the ER     444 – 456  sequence.  It  specifi  cally 
traps ER     in the nuclear compartment of MCF-7 cells and re-
duces the estradiol-induced S phase entry in these cells, thus 
confi  rming that ER     nuclear export plays a key role in DNA 
synthesis of target cells. This view is reinforced by the fi  nding 
that addition of the peptide to the cell medium 1 h after hor-
monal stimulation, when ER     nuclear export is almost complete, 
does not affect estradiol-induced S phase entry in MCF-7 cells. 
Experiments with NIH3T3 fi  broblasts show that an NES-ER    
mutant fails to induce S phase entry in these cells, whereas it 
active proliferation (  Vallejo et al., 2005  ). In addition, the extra-
nuclear cross talk between ER      –  AR and the EGF receptor reg-
ulates EGF-elicited responses such as actin changes and DNA 
synthesis in breast and prostate cancer cells (  Migliaccio et al., 
2005  ). Direct evidence of the proliferative role of the ER    –  A R  
complex association with Src in mammary and prostate cancer 
cell xenografts has been recently described (  Migliaccio et al., 
2007b  ;   Varricchio et al., 2007  ). These and other similar fi  ndings 
point to the critical role of steroid receptor extranuclear localiza-
tion in steroid hormone or growth factor action. 
  In this study, we analyzed the nucleocytoplasmic shuttling 
of ER     in MCF-7 cells, focusing on its export from the nucleus. 
We observed that estradiol induces CRM1-dependent nuclear 
export of ER   .  Thus,  identifi  cation of the ER     sequence  re-
sponsible for its nuclear export was initially performed by a nu-
clear export assay (  Henderson and Eleftheriou, 2000  ). Previous 
studies found that the outward movement of PgR from the nu-
clear compartment is mediated by its NLSs (  Guiochon-Mantel 
et al., 1994  ). We then assayed the ability of ER     NLSs to shift 
the REV mutant into the cytoplasm. Our data show that NLSs 
are not involved in the nuclear export of ER    . It has also been 
hypothesized that the nuclear exit of ER     is regulated by its 
phosphorylation on Thr311 (  Lee and Bai, 2002  ). This residue is 
present in a putative leucine-rich ER     NES (305  –  322 of ER   ), 
which shares homology with the p53 N-terminal NES (  Zhang 
and Xiong, 2001  ). We found that the leucine-rich 296  –  335 ER    
sequence does not drive the REV mutant into the cytoplasm. 
Using the same approach, we observed that the leucine-rich 
  Figure 6.       Estradiol-induced FKHR activation 
and Er      –  FKHR complex assembly in MCF-7 
cells.   Model of ER     nuclear export. Quiescent 
MCF-7 cells were used. (a) Cells were left un-
stimulated or stimulated for 5 min with 10 nM 
estradiol in the absence or presence of LY294002 
(at 5   μ  M; Qbiogene). Lysates were analyzed 
for FKHR phosphorylation using the anti  –  P-Ser-
256  –  FKHR antibody (bottom). The nitrocellu-
lose ﬁ  lter was then reprobed with anti-FKHR 
antibody (top). (b) The cells were transfected 
with the indicated plasmids (FKHR wt or FKHR 
AAA) then left unstimulated or stimulated for 
30 min with 10 nM estradiol. Lysates were 
immunoprecipitated with anti-ER     antibody. 
Immunocomplexes were immunoblotted using 
the antibodies against the indicated proteins. 
(c) The model of ER     nuclear export is de-
picted. Estradiol stimulates the PI3K  –  AKT path-
way, leading to FKHR phosphorylation and 
triggering the functionally associated export of 
FKHR  –  ER    . This export results in stimulation of 
DNA synthesis.     337 ER     NUCLEAR EXPORT AND S PHASE ENTRY IN ESTRADIOL-STIMULATED CELLS   • Lombardi et al. 
gested with KpnI and BamH1 and subcloned into pSG5. cDNA encoding 
the wt of hER     (HEG0) was in the pSG5 expression vector was provided by 
P. Chambon (Institut de G  é  n  é  tique et de Biologie Mol  é  culaire et Cellulaire 
[Centre National de la Recherche Scientiﬁ  que/Institut National de la Sant  é   
et de la Recherche M  é  dicale], Universit  é   Louis Pasteur, Illkirch, France; 
  Tora et al., 1989  ). It was subcloned into EcoRI-pEGFP (C2; Clontech Lab-
oratories, Inc.) or EcoRI-pSG5Myc as described previously (  Castoria et al., 
2004  ). The ER     mutants HEG14, HEG15, and HEG241 in pSG5 were 
provided by P. Chambon (  Tora et al., 1989  ;   Ylikomi et al., 1992  ) were 
digested with EcoRI and ligated into the pEGFP plasmid (C2). pEGFP-NLS/
HEG14 was obtained by digestion of pEGFP-HEG0 with MspI and BamHI 
and subcloned into SmaI  –  BamHI pEGFP. The site-directed mutations of 
ER     were introduced into pSG5-HEG0 using PCR. The pSG5-HEG4A (Ile 
451 and 452 changed with Ala; Leu 453 and 454 changed with Ala) 
and pSG5-HEGIL (Ile 451 changed with Ala; Leu 454 changed with Ala) 
mutants were generated. The cDNAs coding for the ER     mutants (HEG4A 
and HEGIL; ER     4A and ER     IL) were subcloned into EcoRI-pEGFP. All junc-
tions were veriﬁ  ed by DNA sequencing. The dominant-negative form of 
p85     (    p85    ) in pSG5 was provided by J. Downward (Cancer Research 
UK London Research Institute, England, UK;   Dhand et al., 1994  ). The Myc-
His  –  tagged dominant-negative form of AKT (K179M) in the pUSEAmp 
plasmid was obtained from United Biotech Inc. The Myc-tagged pSG5 
was prepared as described previously (  Castoria et al., 2004  ). FKHR wt or 
mutant (FKHR AAA) were in pcDNA-GFP (Addgene). For the export assay, 
the putative export sequences of ER     were cloned into the BamHI and 
AgeI sites of pREV(1.4)-GFP and inserted between the REV and GFP cod-
ing sequence (EGFP-N1; Clontech Laboratories, Inc.). To insert the puta-
tive export ER     sequence into pREV(1.4)-GFP (Rev mutant), a PCR strategy 
was adopted for the following fragments: NLS sequence (241  –  306 aa) 
was ampliﬁ  ed by forward primer 5    -GACTGGATCCAATGATGAAAGGT-
GGGATACGAAAAGACCG-3     and reverse primer 5    -GCGACCGGTGG-
CAGGCTGTTCTTCTTAGAGCGTTTGATCA-3    ; 286 sequence (286  –  311 aa) 
by forward primer 5    -GATCGGATCCAATGAGAGCTGCCAACCTTTG-
GCCAAGCCCG-3     and reverse primer 5    -GCGACCGGTGGGGCCGT-
CAGGGACAAGGCCAGGCTGTTCT-3    ; 286 sequence (286  –  382 aa) by 
reverse primer 5    -GCGACCGGTGGGGCACATTCTAGAAGGTGGACCT-
GATCATG-3    ; 296 sequence (296  –  335 aa) by forward primer 5    -GATC-
GGATCCAATGATCAAACGCTCTAAGAAGAAC-3     and reverse primer 
5    -GCGACCGGTGGGGGTCTGGTAGGATCATACTCGGAATAGA-3    ; 316 
sequence     (316  –  335 aa) by forward primer 5    -GATCGGATCCAAGTG-
CCTTGTTGGATGCTGAGCCCCCCAT-3    ; 341 sequence (341  –  361 aa) by 
forward primer 5    GATCGGATCCATCGATGATGGGCTTACTGACCA  AC-
CTGGC-3     and reverse primer 5    -GCGACCGGTGGCGCCCAGTTGAT-
CATGTGAACCAGCTCCC-3    ; 368 sequence (368  –  394 aa) by forward 
primer 5   -GATCGGATCCAGTGGATTTGACCCTCCATGATCAGGTCCA-3     
and reverse primer 5    -GCGACCGGTGGGCGCCAGACGAGACCAATCAT-
CAGGATCT-3    ; 381 sequence (381  –  412 aa) by forward primer 5    -GATC-
GGATCCATGTGCCTGGCTAGAGATCCTGATGATTGGT-3     and reverse 
primer 5    -GCGACCGGTGGGTTCCTGTCCAAGAGCAAGTTAGGAG-
CAA-3    ; 395 sequence (395  –  412 aa) by forward primer 5    GATCGG-
ATCCATCCATGGAGCACCCAGTGAAGCTACTGTT-3    ; 427 sequence 
(427  –  457 aa) by forward primer 5    -GATCGGATCCAATGCTGCTGGC-
TACATCATCTCGGTTCCG-3     and reverse primer 5    -GCGACCGGTGGTC-
CAGAATTAAGCAAAATAATAGATTTGAGGCACAC-3    ; 381  –  457 sequence; 
and 458  –  552 sequence by forward primer 5    -GATCGGATCCAGTGTA-
CACATTTCTGTCCAGCACCCTGAAGTCT-3     and reverse primer 5    -GCG-
ACCGGTGGGGGCGCATGTAGGCGGTGGGCGTCCAGCATCTC-3    . 
All these fragments were ampliﬁ  ed using Platinum Pfx (Invitrogen) accord-
ing to the manufacturer  ’  s instructions. PCR products were puriﬁ  ed, digested 
with BamHI  –  AgeI, and ﬁ  nally subcloned into pREV(1.4)-GFP (Rev mutant). 
The ER     444  –  456 sequence was subcloned in the same vector as a short 
fragment generated by annealing of speciﬁ  c oligonucleotides. The same 
strategy was used to generate the ER     444  –  456 mutant. All putative NES-
ER    s were veriﬁ  ed by sequencing to conﬁ  rm the exact reading frame be-
tween REV and GFP. 
  Cell culture, transfection, and siRNA 
  Human breast cancer  –  derived MCF-7 cells and low-passage mouse em-
bryo NIH3T3 ﬁ  broblasts were grown and made quiescent as described 
previously (  Castoria et al., 1999  ,   2003  ). Unless otherwise stated, quies-
cent MCF-7 cells on coverslips were transfected with 1   μ  g of each puriﬁ  ed 
plasmid using the SuperFect reagent (QIAGEN). Silencing of ER     was si-
lenced by siRNA as described previously (  Migliaccio et al., 2005  ), and 
puriﬁ  ed GFP-FKHR wt was cotransfected at 0.5   μ  g. Nontargeting siRNA 
was used as a control, according to the same study (  Migliaccio et al., 2005  ). 
activates gene transcription. These fi  ndings further point to the 
role of ER     nuclear export in cell cycle progression modulated 
by estrogens in breast cancer cells. 
  The function of many proteins is regulated by their sub-
cellular localization. These proteins include cell cycle regula-
tors and transcription factors, such as nuclear factor    B,  p53, 
and mammalian members of the FHKR transcription factors 
(for review see   Kau and Silver, 2003  ). A triple alanine mutant of 
FKHR localizes in the nucleus and induces G1 arrest of cells 
(  Nakamura et al., 2000  ;   Birkenkamp and Coffer, 2003  ). Consis-
tent with the hypothesis that permanent localization of tran-
scription factors in the nucleus can stop the cell cycle, it has 
been shown that estradiol stimulation of Pak-1 and ER     pro-
motes cell survival by inducing phosphorylation and nuclear 
exclusion of Foxo1 in breast cancer cells (  Mazumdar and Kumar, 
2003  ). Relevant to the observed association between estradiol-
regulated export of ER     and FKHR, an estradiol-dependent 
interaction between ER     and FKHR has been observed using a 
yeast two-hybrid screen and in vitro pull-down experiments 
(  Schuur et al., 2001  ). Extension of these investigations to other 
nuclear receptor family members has shown that, depending on 
the receptor type, FKHR represents a bifunctional intermediary 
protein acting as either a coactivator or corepressor of these re-
ceptors (  Zhao et al., 2001  ). 
  Estradiol stimulation of MCF-7 cells triggers DNA syn-
thesis through PI3K- and Src-dependent pathway activation, 
which causes an increase in cyclin D1 transcription and p27 nu-
clear release (  Castoria et al., 2001  ,   2004  ). We observe here that 
estradiol-activated AKT phosphorylates FKHR, thus triggering 
the FKHR  –  ER     association and facilitating the nuclear export of 
the complex. By removing the inhibitory action of FKHR, this 
event triggers cell cycle progression. Increased FKHR  –  Ser-256 
phosphorylation by estradiol activation of AKT has been recently 
described in neuronal cells (  Won et al., 2006  ). Association of 
FKHR with ER    , as indicated by their colocalization and co-
immunoprecipitation, might favor FKHR nuclear exit by masking 
its NLS. A similar interaction with FKHR has been described for 
the 14-3-3 protein (for review see   Van Der Heide et al., 2004  ). 
  Our present results provide further insight on regulation 
of ER     intracellular traffi  cking and demonstrate the key role of 
estradiol rapid action in modulating this process. We have iden-
tifi  ed for the fi  rst time a functional NES of ER   .  Targeting  of 
this motif by synthetic peptides or site-directed mutagenesis 
modulates ER     subcellular localization and impairs estradiol-
induced S phase entry in target cells. The model of ER     nuclear 
export is depicted in   Fig. 6 c  . 
 Our  fi  ndings highlight the biological functions of this 
receptor and offer a powerful tool to modify the intracellular 
distribution of ER    . A strategy of trapping ER     in nuclear com-
partment using peptides derived from the NES-ER     might be a 
potential approach to the therapy of human breast cancer. 
  Materials and methods 
  Constructs 
  The constitutive active Ran Q69L was in the pQE plasmid was a gift of 
I.W. Mattaj (European Molecular Biology Laboratory, Heidelberg, Germany; 
  Izaurralde et al., 1997  ). The pCDNA/HA-CRM1 (  Alt et al., 2000  ) was di-JCB • VOLUME 182 • NUMBER 2 • 2008  338
  Puriﬁ  ed proteins and in vitro protein  –  protein interactions 
  Ran Q69L expressed in JM109 bacteria was puriﬁ  ed using the Ni-NTA 
agarose (QIAGEN) and recombinant human ER     (2800 pmol/ml; Invitro-
gen). S 
35  -labeled HA-CRM1 was produced in rabbit reticulocyte lysate 
(Promega), and protein  –  protein interaction was performed as described 
previously (  Migliaccio et al., 2000  ). Immunoprecipitation was performed 
using the rabbit polyclonal anti-ER     Ab (G-20 1   μ  g/ml; Santa Cruz Biotech-
nology, Inc.) or the mouse monoclonal anti-HA antibody (at 2   μ  g/ml; 
Covance). Eluted proteins were analyzed by immunoblotting or ﬂ  uorography. 
  Lysates, immunoprecipitation, and immunoblotting 
  Lysates were prepared as described previously (  Migliaccio et al., 2000  ), 
and ER     was immunoprecipitated according to the same protocol. Rabbit 
polyclonal anti-ER     antibody (G-20; Santa Cruz Biotechnology, Inc.) was 
used to detect ER    . P-Ser473-AKT and AKT from cell lysates were de-
tected as described previously (  Castoria et al., 2001  ). P-Ser256-FKHR 
and FKHR were revealed by Western blotting using the appropriate anti-
bodies (Cell Signaling Technology). Expression and production of Ran 
Q69L was veriﬁ  ed using the mouse monoclonal anti-His tag antibody 
(QIAGEN). When indicated, ER     and the chimera GFP-ER     were de-
tected using either the rat monoclonal (H222; Abbott Labs) anti-ER     anti-
body or the mouse mono  clonal anti-GFP antibody (Clontech Laboratories, 
Inc.). Immunoreactive proteins were revealed by the ECL detection system 
(GE Healthcare). 
  Online supplemental material 
  Fig. S1 shows the cytoplasmic localization of endogenous ER     in indirect 
IF staining of untreated or estradiol-treated MCF-7 cells. Corresponding 
cell lysates do not show signiﬁ  cant change in ER     or GFP-ER     levels. 
The ﬁ  gure also presents images from experiments shown in the paper 
as well as estradiol activation of Akt in MCF-7 cells. Fig. S2 shows that 
the NLS  –  HEG14 construct, which is made up of the nuclear localization 
signals and the hormone binding domain of ER     contains the NES-ER    . 
Fig. S3 shows the homology between the 444  –  456 amino acids of ER     
and the conserved leucine-rich and REV-like NES of p53. It also shows that 
the 444  –  456 sequence of ER     is highly conserved among the members 
of steroid receptor family. The speciﬁ  city of Tat-conjugated peptide is also 
presented. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200712125/DC1. 
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